机读格式显示(MARC)
- 000 02004cam a2200361 i 4500
- 008 191213s2020 nyua b 001 0 eng
- 020 __ |a 9781108479448 (hardback)
- 020 __ |a 9781108749060 (paperback)
- 020 __ |z 9781108785549 |q (ebook)
- 040 __ |a DLC |b eng |e rda |c DLC
- 050 00 |a R855.3 |b .B87 2020
- 245 04 |a The business of healthcare innovation / |c Lawton Robert Burns, Wharton School, University of Pennsylvania.
- 264 _1 |a Cambridge, United Kingdom ; |a New York, NY : |b Cambridge University Press, |c 2020.
- 300 __ |a xxvi, 492 p. : |b illustrations (black and white) ; |c 26 cm
- 336 __ |a text |b txt |2 rdacontent
- 337 __ |a unmediated |b n |2 rdamedia
- 338 __ |a volume |b nc |2 rdacarrier
- 504 __ |a Includes bibliographical references and index.
- 520 __ |a "Perhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional $6.3 billion in funding for the National Institutes of Health (NIH) and other agencies"-- |c Provided by publisher.
- 650 _0 |a Medical care |x Technological innovations.
- 650 _0 |a Medical technology |x Economic aspects.
- 650 _0 |a Business forecasting.
- 650 _0 |a Economic forecasting.
- 700 1_ |a Burns, Lawton R., |e editor.
- 776 08 |i Online version: |t The business of healthcare innovation |d New York : Cambridge University Press, 2020. |z 9781108785549 |w (DLC) 2019039715